The Board of Directors of Pharmesis International Ltd. referred to the announcement made on 6 February 2020 regarding the temporary closure of its production facilities. The board announced that its production facility in Chengdu, China, has resumed operations with the approval of the local Chinese authorities. Its production facility in Gulin, China, remains temporarily closed until further notice as directed from the local Chinese authorities in response to the COVID-19 (Coronavirus Disease 2019) situation. The group is closely monitoring the situation and shall keep shareholders informed of any material developments as and when they arise.